Bret Christensen Insulet Corp (PODD) insider trading activity

Bret Christensen is EVP and CCO of INSULET CORP. Currently has a direct ownership of 17,917 shares of PODD, which is worth approximately $4.25 Million. The most recent transaction as insider was on Feb 28, 2023, when has been sold 349 shares (Common Stock) at a price of $276.36 per share, resulting in proceeds of $96,449. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.9K

0% 3M change

0% 12M change

Total Value Held $4.25 Million

Bret Christensen Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 28 2023	SELL Payment of exercise price or tax liability	$96,449 $276.36 p/Share	349 Reduced 1.91%	17,917 Common Stock
Feb 28 2023	BUY Grant, award, or other acquisition	-	2,261 Added 10.08%	20,178 Common Stock
Feb 17 2023	SELL Payment of exercise price or tax liability	$353,424 $296.0 p/Share	1,194 Reduced 6.14%	18,266 Common Stock
Feb 17 2023	BUY Grant, award, or other acquisition	-	3,108 Added 13.87%	19,307 Common Stock
Feb 10 2023	SELL Payment of exercise price or tax liability	$58,671 $294.83 p/Share	199 Reduced 1.2%	16,352 Common Stock
Nov 18 2022	SELL Open market or private sale	$885,449 $295.15 p/Share	3,000 Reduced 15.34%	16,551 Common Stock
Aug 24 2022	SELL Open market or private sale	$766,296 $264.24 p/Share	2,900 Reduced 12.92%	19,551 Common Stock
Feb 28 2022	BUY Grant, award, or other acquisition	-	2,361 Added 9.55%	22,363 Common Stock
Feb 26 2022	SELL Payment of exercise price or tax liability	$142,205 $262.37 p/Share	542 Reduced 2.64%	20,002 Common Stock
Feb 18 2022	SELL Payment of exercise price or tax liability	$652,660 $234.18 p/Share	2,787 Reduced 11.95%	20,544 Common Stock
Feb 18 2022	BUY Grant, award, or other acquisition	-	7,329 Added 23.9%	23,331 Common Stock
Feb 17 2022	SELL Payment of exercise price or tax liability	$36,844 $240.81 p/Share	153 Reduced 0.95%	16,002 Common Stock
Feb 10 2022	SELL Payment of exercise price or tax liability	$50,309 $252.81 p/Share	199 Reduced 1.22%	16,155 Common Stock
Aug 26 2021	SELL Open market or private sale	$882,390 $294.13 p/Share	3,000 Reduced 15.52%	16,331 Common Stock
Aug 18 2021	BUY Exercise of conversion of derivative security	$128,460 $42.82 p/Share	3,000 Added 13.43%	19,331 Common Stock
Feb 26 2021	SELL Payment of exercise price or tax liability	$156,237 $259.1 p/Share	603 Reduced 3.58%	16,259 Common Stock
Feb 17 2021	SELL Payment of exercise price or tax liability	$514,070 $279.69 p/Share	1,838 Reduced 9.83%	16,862 Common Stock
Feb 17 2021	BUY Grant, award, or other acquisition	-	5,698 Added 23.35%	18,700 Common Stock
Feb 12 2021	SELL Payment of exercise price or tax liability	$155,896 $289.77 p/Share	538 Reduced 3.97%	13,002 Common Stock
Feb 10 2021	SELL Payment of exercise price or tax liability	$55,190 $280.15 p/Share	197 Reduced 1.43%	13,540 Common Stock

Also insider at

DMTK

DermTech, Inc. Healthcare

Chief Executive Officer